ChemSpider 2D Image | MFCD00058004 | C16H25ClN2O4

MFCD00058004

  • Molecular FormulaC16H25ClN2O4
  • Average mass344.834 Da
  • Monoisotopic mass344.150299 Da
  • ChemSpider ID10131731
  • defined stereocentres - 3 of 3 defined stereocentres


More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

65391-42-6 [RN]
Bestatin [Trade name]
Bestatin hydrochloride
L-Leucine, N-[(2S,3R)-3-amino-2-hydroxy-1-oxo-4-phenylbutyl]-, hydrochloride (1:1) [ACD/Index Name]
MFCD00058004
N-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutanoyl]-L-leucine hydrochloride (1:1) [ACD/IUPAC Name]
N-[(2S,3R)-3-Amino-2-hydroxy-4-phénylbutanoyl]-L-leucine, chlorhydrate (1:1) [French] [ACD/IUPAC Name]
N-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutanoyl]-L-leucinhydrochlorid (1:1) [German] [ACD/IUPAC Name]
N-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine hydrochloride
(-)-bestatin hydrochloride
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

4628066 [DBID]
B8385_SIGMA [DBID]
EU-0100214 [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Chemical Class:

      Biochemistry EU-OpenScreen [B 8385]
    • Bio Activity:

      Aminopeptidase MedChem Express HY-B0134A
      Bestatin hydrochloride (Ubenimex ) is a competitive aminopeptidase inhibitor, which is studied for use in the treatment of acute myelocytic leukemia. MedChem Express
      Bestatin hydrochloride (Ubenimex ) is a competitive aminopeptidase inhibitor, which is studied for use in the treatment of acute myelocytic leukemia.; Target: aminopeptidase; Bestatin, also known as Ubenimex (INN), is a competitive protease inhibitor. MedChem Express HY-B0134A
      Bestatin hydrochloride (Ubenimex ) is a competitive aminopeptidase inhibitor, which is studied for use in the treatment of acute myelocytic leukemia.;Target: aminopeptidaseBestatin, also known as Ubenimex (INN), is a competitive protease inhibitor. It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia.Bestatin can be administered, with low toxicity, to cultured cells, intact animals and humans. It has become a useful tool in elucidating the physiological role of some mammalian exopeptidases in the regulation of the immune system, in the growth of tumors and their invasion of surrounding tissues, and in the degradation of cellular proteins. MedChem Express HY-B0134A
      Metabolism/Protease MedChem Express HY-B0134A
      Metabolism/Protease; MedChem Express HY-B0134A

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site






Advertisement